|
Hoji Alimi
Mike Wokasch
James Schutz
Robert Miller
Michelle Carpenter
Bruce Thornton
Andres Gutiérrez
Robert Northey
|
Hoji Alimi
Chief Executive Officer, President and Chairman of the Board
Hojabr Alimi, one of our founders, has served as our chief executive officer, president and director since 1999 and was appointed as chairman of the board of directors in June 2006. Prior to co-founding our company with his spouse in 1999, Mr. Alimi was a corporate microbiologist for Arterial Vascular Engineering. Mr. Alimi received a B.A. in biology from Sonoma State University.
Mike Wokasch
Chief Operating Officer
Michael Wokasch has served as our chief operating officer since June 2006. From July 2004 to May 2006, Mr. Wokasch served as senior vice president global commercial operations for the biopharmaceuticals division of Chiron Corporation, a biotechnology company. He served as chief operating officer of Impax Laboratories, a pharmaceutical company, from January 2003 to June 2004. Prior to Impax, Mr. Wokasch served as president of PanVera Corporation and then Aurora Biosciences Corporation, both drug discovery subsidiary companies of Vertex Pharmaceuticals, from July 2001 to December 2002, and as chief executive officer of Gala Design, a biotechnology company, from June 2000 to July 2001. Prior to this, Mr. Wokasch also served as a president and corporate senior vice president at Covance from 1997 to 1999, a contract research organization. Mr. Wokasch received a B.S. from the University of Minnesota, college of pharmacy.
James Schutz
Vice President of Corporate Development, General Counsel, Corporate Secretary and Director
James Schutz has served as our vice president of corporate development and general counsel since August 2003, as a director since May 2004 and corporate secretary since June 2006. From August 2001 to August 2003, Mr. Schutz served as general counsel at Jomed (formerly EndoSonic Corp.), an international medical device company. From 1999 to July 2001, Mr. Schutz served as in-house counsel at Urban Media Communications Corporation, an Internet/telecom company based in Palo Alto, California. Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.
Robert Miller
Chief Financial Officer
Robert Miller has served as our chief financial officer since June 2004 and was a consultant to us from March 2003 to May 2004. Mr. Miller has served as a director of Scanis, Inc. since 1998 and served as acting chief financial officer from 1998 to June 2006. He was a chief financial officer consultant to Evit Labs from June 2003 to December 2004, Wildlife International Network from October 2002 to December 2005, Endoscopic Technologies from November 2002 to March 2004, Biolog from January 2000 to December 2002 and Webware from August 2000 to August 2002. Prior to this, Mr. Miller was the chief financial officer for GAF Corporation, Penwest Ltd. and Bugle Boy and treasurer of Mead Corporation. He received a B.A. in economics from Stanford University and an M.B.A. in finance from Columbia University.
Michelle Carpenter
Vice President of Regulatory Affairs and Quality
Michelle Carpenter has served as vice president of regulatory affairs and quality since April 2008. Most recently, she served as vice president of regulatory/medical affairs and chief compliance officer at DEY, L.P., a pharmaceutical drug delivery company where she developed and implemented clinical and regulatory strategies. She has been responsible for several successful IND, NDA and MAA regulatory filings during her career. Ms. Carpenter started her career at Oclassen Pharmaceuticals before moving into regulatory affairs at Insite Vision and then at Santen, where she served as global vice president of regulatory and project management. Ms. Carpenter received her doctor of jurisprudence from Golden Gate University school of law with an emphasis on health law. She earned an undergraduate degree in sociology with the majority of her coursework in pre-medicine at the University of California at Santa Barbara.
Bruce Thornton
Vice President of International Operations and Sales
Bruce Thornton has served as our vice president of international operations and sales since June 2005. Mr. Thornton served as our general manager for U.S. operations from March 2004 to July 2005. He served as vice president of operations for Jomed (formerly EndoSonic Corp.) from January 1999 to September 2003, and as vice president of manufacturing for Volcano Therapeutics, an international medical device company, following its acquisition of Jomed, until March 2004. Mr. Thornton received a B.S. in aeronautical science from Embry-Riddle Aeronautical University and an M.B.A. from National University.
Andres Gutiérrez M.D., Ph.D.
Director of Medical Affairs
Andres Gutiérrez, M.D., Ph.D. has served as our director of medical affairs since August 2005. Dr. Gutiérrez served as a consultant to us from April 2003 to July 2005. He served as the head of the cell therapy unit at the National Institute of Rehabilitation in Mexico City from September 2000 to July 2005 and as a consulting physician with the department of medicine at Hospital Angeles del Pederegal in Mexico City from 1996 to July 2005. He received an M.D. with a specialty in internal medicine, and a Ph.D. in biomedical sciences, each from the National University of Mexico in Mexico City.
Robert Northey Ph.D
Director of Research and Development
Robert Northey, Ph.D. has served as our director of research and development since July 2005. Dr. Northey served as a consultant to us from May 2001 to June 2005. From August 1998 until June 2005, he was an assistant professor in the paper science and engineering department at the University of Washington. Dr. Northey received a B.S. in wood and fiber science and a Ph.D. in wood chemistry, each from the University of Washington.
|
